MicroRNA blood test identifies severe malaria in children January 13, 2021 -- A blood test for microRNAs shows promise for identifying children with severe forms of malaria and treating them accordingly, according to a new study published in Emerging Infectious Diseases, a journal of the U.S. Centers for Disease Control and Prevention.
BD sees Q1 revenues up 26% as COVID-19 testing drives sales January 13, 2021 -- Becton Dickinson (BD) is projecting revenues for its fiscal first quarter to grow 26% as sales of COVID-19 testing products hit $865 million -- contributing 20 percentage points to revenue growth for the quarter.
Delfi raises $100M to develop liquid biopsy for multiple cancers January 13, 2021 -- Delfi Diagnostics has raised $100 million in a fundraising round with existing and new investors to help the company fund development of its liquid biopsy technology to detect multiple types of cancer.
Freenome touts ASCO study of blood test for colorectal adenomas January 12, 2021 -- Freenome is highlighting the results of a clinical study of its blood test for detecting colorectal advanced adenomas to be presented at the American Society of Clinical Oncology's (ASCO) Gastrointestinal Cancers Symposium, January 15-17.
COVID-19 pandemic accelerates adoption of diagnostic testing at point of care January 11, 2021 -- Out of a very bad year where the COVID-19 pandemic brought the world to its knees has come some good, investors say. Point-of-care diagnostics tests are flourishing, according to panelists at the Biotech Showcase investor conference, held online from January 11-15. Discuss
Abbott wins FDA nod for blood test to diagnose concussion January 11, 2021 -- Abbott has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a rapid blood test to assist with the diagnosis of concussions and other mild traumatic brain injuries.
Grail to collaborate with top companies for MRD detection January 11, 2021 -- Cancer diagnostics startup Grail has announced collaborations with Amgen, AstraZeneca, and Bristol Myers Squibb to evaluate the ability of Grail's methylation-based platform to detect minimal residual disease (MRD).
Diagnostics growth drives Hologic's Q1 results higher January 8, 2021 -- Strong growth in its molecular diagnostics business -- with revenues almost tripling due to the COVID-19 pandemic -- helped drive first-quarter preliminary financial results for Hologic.
Everlywell, Gingko Bioworks to distribute COVID-19 antigen test January 8, 2021 -- Everlywell has signed an agreement with Ginkgo Bioworks to distribute Access Bio's CareStart COVID-19 antigen test to workplaces, clinics, schools, government offices, and health plans.